PMP-20-145C: Avanos RF Probe, Reusable, Curved 20G x 145mm (Non-Sterile)

Sign in to add this product to your favorites!
| Price: | $899.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | Non-sterile |
AccessGUDID Info
- FDA Product Code: GXI
- FDA Product Code Name: Probe, radiofrequency lesion
- GMDN Term Code: 62025
- GMDN Term Name: Percutaneous radio-frequency ablation probe, denervation, monopolar, reusable
- GMDN Term Description: A semi-flexible, hand-held surgical instrument intended to be percutaneously introduced via a dedicated cannula [under x-ray, ultrasound (US) or other external image guidance] to deliver radio-frequency current, in a monopolar configuration, from a system generator directly to peripheral nerve tissues to coagulate/ablate them for the treatment of pain. It includes a distal monopolar electrode which may include temperature-sensing elements; the introduction cannula may be included. This is a reusable device.
More on Ablation | RF
Radiofrequency (RF) Ablation is a widely used thermal ablation technique that destroys targeted tissue by delivering high-frequency alternating current through a catheter or probe. The electrical energy creates heat, leading to localized coagulative necrosis and cell death. In cardiology, RF ablation is a cornerstone treatment for arrhythmias like atrial fibrillation, while in oncology, it’s used to treat tumors in the liver, kidney, lung, and other organs. RF ablation is valued for its precision, proven track record, and ability to be performed in a minimally invasive setting, often under imaging guidance.
Manufacturer
Avanos Medical is a global medical technology company specializing in innovative healthcare solutions for pain management and digestive health. With a focus on improving patient outcomes and reducing reliance on opioids, Avanos develops advanced solutions such as radiofrequency ablation for chronic pain, enteral feeding systems, and airway management products. Headquartered in Alpharetta, Georgia, Avanos serves healthcare providers worldwide with a commitment to safety, quality, and innovation. Through its clinically proven technologies, the company continues to enhance patient care across hospitals, outpatient facilities, and home settings.
IN-DATE